尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by OConnell Daniel Joseph, 董事长兼首席执行官. Insider active across 1 company, notably Acumen Pharmaceuticals, Inc.. Cumulatively, 12 disclosures have been recorded. Breakdown: 0 buy · 6 sells. Total volume traded: €188k. Activity tracked since 30 November 2021. The latest transaction was disclosed on 21 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
OConnell Daniel Joseph is Président-Directeur Général and Chief Executive Officer at Acumen Pharmaceuticals, Inc. The record shows 12 filings in total, and across the 12 sampled filings between 2021-07-08 and 2026-01-23, the modal transaction nature is sale, with total sales of EUR 188309 and no purchases reported.